Immunosuppression regimen and latitude impact keratinocyte carcinoma risk in U.S. liver transplant recipients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Immunosuppression regimen and latitude impact keratinocyte carcinoma risk in U.S. liver transplant recipients ; volume:316 ; number:9 ; day:26 ; month:9 ; year:2024 ; pages:1-10 ; date:11.2024
Archives of dermatological research ; 316, Heft 9 (26.9.2024), 1-10, 11.2024
- Creator
-
Rosenthal, Benjamin E.
Schaubel, Douglas E.
Lewis, James D.
Margolis, David J.
Goldberg, David S.
Bittermann, Therese
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00403-024-03404-3
- URN
-
urn:nbn:de:101:1-2501152103524.238406156211
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rosenthal, Benjamin E.
- Schaubel, Douglas E.
- Lewis, James D.
- Margolis, David J.
- Goldberg, David S.
- Bittermann, Therese
- SpringerLink (Online service)
Other Objects (12)
Immunosuppression Considerations for Older Kidney Transplant Recipients
Pathways from Diagnosis to Death from Keratinocyte Cancer in Kidney Transplant Recipients
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group
Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
Novel ways to monitor immunosuppression in pediatric kidney transplant recipients—underlying concepts and emerging data
Immunomonitoring in Transplant Recipients
T-cell specific antibody induction versus corticosteroid induction immunosuppression for liver transplant recipients: a meta-analysis
Management of immunosuppression in lung transplant recipients and COVID-19 outcomes: an observational retrospective cohort-study
Correction to: Novel ways to monitor immunosuppression in pediatric kidney transplant recipients—underlying concepts and emerging data
NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging
Malignant tumors in organ transplant recipients
Immunosuppression Considerations for Older Kidney Transplant Recipients
Pathways from Diagnosis to Death from Keratinocyte Cancer in Kidney Transplant Recipients
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group
Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
Novel ways to monitor immunosuppression in pediatric kidney transplant recipients—underlying concepts and emerging data
Immunomonitoring in Transplant Recipients
T-cell specific antibody induction versus corticosteroid induction immunosuppression for liver transplant recipients: a meta-analysis
Management of immunosuppression in lung transplant recipients and COVID-19 outcomes: an observational retrospective cohort-study
Correction to: Novel ways to monitor immunosuppression in pediatric kidney transplant recipients—underlying concepts and emerging data
NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging
Malignant tumors in organ transplant recipients
Immunosuppression Considerations for Older Kidney Transplant Recipients
Pathways from Diagnosis to Death from Keratinocyte Cancer in Kidney Transplant Recipients
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group
Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
Novel ways to monitor immunosuppression in pediatric kidney transplant recipients—underlying concepts and emerging data
Immunomonitoring in Transplant Recipients
T-cell specific antibody induction versus corticosteroid induction immunosuppression for liver transplant recipients: a meta-analysis
Management of immunosuppression in lung transplant recipients and COVID-19 outcomes: an observational retrospective cohort-study
Correction to: Novel ways to monitor immunosuppression in pediatric kidney transplant recipients—underlying concepts and emerging data
NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging